Is the writing on the wall?

Discussion in 'Vanda Pharmaceuticals' started by anonymous, Jan 30, 2018 at 1:55 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I loved the continual blame on payers that sales aren't higher. Using one bizarre rejection as the case was pathetic. Most payers will continue to reject hetlioz since these patients don't have non 24, they have insomnia and hetlioz is not indicated for insomnia and there are many medications for insomnia that are much better than the sugar pill called Hetlioz that costs nearly $200000 per year.
     

  2. anonymous

    anonymous Guest

    absolutely incredible. The level of arrogance by Poly. Unfortunately, investors, through the share price, are rewarding him for this behavior. He is emboldened. Now, going to try to fight FDA. This could be a big misstep.
    Also, the pricing is hilarious -- just look in the SEC filings, it clearly states that payer do not think Hetlioz is "cost effective." But Poly continues to tell investors that price is not a point of negotiation because it is priced appropriately. He must not engage at all with the non-24 community. Everyone would tell him that price is an issue, whether they are on the drug, can't get the drug, or have not even tried because of the prohibitive process/price. Just goes to show how detached he is and how little he actually cares about patients. All he cares about are intakes and ability to recognize revenues.
     
  3. anonymous

    anonymous Guest

    See "Dear Associate Reps " thread and a few of the older threads. Representatives that refused to break federal law were purged by MP, GP and TG. But being jobless is better than federal prison.
     
  4. anonymous

    anonymous Guest

    Poly would personally like out eyeballs to make someone blind and them ask if they would like Hetlioz.
     
  5. anonymous

    anonymous Guest

    POKE out eyeballs not like.